Evolus (EOLS) Revenue & Revenue Breakdown
Evolus Revenue Highlights
Latest Revenue (Y)
$199.72M
Latest Revenue (Q)
$60.16M
Main Segment (Y)
Product
Main Geography (Y)
CANADA
Evolus Revenue by Period
Evolus Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $199.72M | 34.39% |
2022-12-31 | $148.62M | 49.10% |
2021-12-31 | $99.67M | 76.29% |
2020-12-31 | $56.54M | 61.89% |
2019-12-31 | $34.92M | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | - |
Evolus Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $60.16M | -10.08% |
2024-06-30 | $66.91M | 12.77% |
2024-03-31 | $59.33M | -2.73% |
2023-12-31 | $61.00M | 23.67% |
2023-09-30 | $49.32M | -0.05% |
2023-06-30 | $49.35M | 18.28% |
2023-03-31 | $41.72M | -4.41% |
2022-12-31 | $43.65M | 28.75% |
2022-09-30 | $33.90M | -8.78% |
2022-06-30 | $37.16M | 9.60% |
2022-03-31 | $33.91M | -2.16% |
2021-12-31 | $34.66M | 29.91% |
2021-09-30 | $26.68M | 2.22% |
2021-06-30 | $26.10M | 113.20% |
2021-03-31 | $12.24M | -40.51% |
2020-12-31 | $20.58M | 16.51% |
2020-09-30 | $17.66M | 126.25% |
2020-06-30 | $7.81M | -25.63% |
2020-03-31 | $10.50M | -46.03% |
2019-12-31 | $19.45M | 47.69% |
2019-09-30 | $13.17M | 469.75% |
2019-06-30 | $2.31M | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | - |
Evolus Revenue Breakdown
Evolus Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Product | $199.72M | $146.59M | $98.97M | $55.80M | $34.24M |
Service | $2.36M | $2.02M | - | - | - |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Dec 20 | Sep 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product | $60.16M | $66.22M | $58.96M | $60.67M | $49.32M | $48.68M | $41.05M | $42.99M | $33.22M | $37.16M | $33.23M | $34.66M | $26.68M | $25.40M | $20.58M | $16.92M |
Service | $921.00K | $687.00K | $369.00K | $328.00K | $696.00K | $666.00K | $674.00K | $658.00K | $684.00K | - | - | - | - | - | - | - |
Latest
Evolus Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 21 | Dec 20 |
---|---|---|
CANADA | $702.00K | $738.00K |
Latest
Quarterly Revenue by Country
Country | Mar 22 | Jun 21 | Sep 20 |
---|---|---|---|
CANADA | $682.00K | $702.00K | $738.00K |
Latest
Evolus Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ALKS | Alkermes | $1.66B | $378.14M |
PBH | Prestige Consumer Healthcare | $1.13B | $283.55M |
PAHC | Phibro Animal Health | $977.89M | $273.16M |
PCRX | Pacira BioSciences | $674.98M | $168.57M |
SUPN | Supernus Pharmaceuticals | $607.52M | $175.69M |
AMPH | Amphastar Pharmaceuticals | $593.24M | $188.82M |
COLL | Collegium Pharmaceutical | $566.77M | $159.30M |
ANIP | ANI Pharmaceuticals | $486.82M | $148.33M |
ITCI | Intra-Cellular Therapies | $462.18M | $175.38M |
PROC | Procaps Group | $409.92M | $118.41M |
EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
EOLS | Evolus | $199.72M | $60.16M |
DCPH | Deciphera Pharmaceuticals | $163.36M | $45.00M |
SSIC | Silver Spike Investment | $11.72M | $2.76B |
IXHL | Incannex Healthcare | - | $12.00K |